東方中科(002819.SZ)擬放棄東科保理40%股權優先受讓權
格隆匯5月15日丨東方中科(002819.SZ)公佈,2020年5月15日,公司四屆二十次董事會審議通過了《關於放棄控股子公司部分股權優先受讓權的議案》,公司控股子公司東科(上海)商業保理有限公司(以下簡稱“東科保理”)持股40%的股東上海皓鋭企業諮詢有限公司(以下簡稱“上海皓鋭”)擬轉讓其持有的全部東科保理股權與永新盈凱企業管理中心(有限合夥)(以下簡稱“永新盈凱”)。上海皓鋭與永新盈凱股權結構一致,公司擬放棄東科保理部分股份的優先轉讓權。轉讓後公司所持東科保理股份比例不發生任何變動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.